FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study - PubMedTwitterFacebookLinkedInGitHubTwitterSM-FacebookSM-Youtube

Both sequences achieved a prolonged survival and similar efficacy. The toxicity profiles were different.